HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alan Saven Selected Research

Hairy Cell Leukemia

5/2022Long-term outcomes of elderly hairy cell leukemia patients treated with cladribine.
11/2019Novel therapeutics in hairy cell leukemia.
1/2019Secondary malignancies after treatment with single-agent vemurafenib in two patients with refractory hairy cell leukemia.
1/2016Current Therapy and New Directions in the Treatment of Hairy Cell Leukemia: A Review.
10/2015Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.
1/2014Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series.
2/2012Targeting B lymphoma with nanoparticles bearing glycan ligands of CD22.
6/2011Development of cladribine at Scripps for hairy cell leukemia and current results.
12/2010Hairy cell leukemia: current therapies and future directions.
3/2010Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alan Saven Research Topics

Disease

16Hairy Cell Leukemia
05/2022 - 03/2003
12Neoplasms (Cancer)
02/2022 - 12/2003
5Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2014 - 09/2003
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2016 - 01/2006
3Lymphoma (Lymphomas)
02/2012 - 06/2010
3Breast Neoplasms (Breast Cancer)
05/2010 - 08/2003
2COVID-19
02/2022 - 01/2021
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2019 - 10/2010
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
04/2016 - 04/2008
2B-Cell Lymphoma (Lymphoma, B Cell)
02/2012 - 06/2010
2Residual Neoplasm
06/2011 - 03/2010
2Hematologic Neoplasms (Hematological Malignancy)
10/2010 - 10/2004
2Leukemia
06/2010 - 12/2006
2Febrile Neutropenia
05/2010 - 08/2003
2Neoplasm Metastasis (Metastasis)
12/2004 - 08/2003
1Pancytopenia
05/2022
1Splenomegaly
05/2022
1Hemorrhage
04/2016
1Back Pain (Backache)
04/2016
1Arthritis (Polyarthritis)
10/2015
1Exanthema (Rash)
10/2015
1Arthralgia (Joint Pain)
10/2015
1Rare Diseases (Rare Disease)
10/2014
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2010
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2010
1Neutropenia
05/2010
1Ovarian Neoplasms (Ovarian Cancer)
05/2010
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
05/2008
1Prostatic Neoplasms (Prostate Cancer)
05/2008
1Systemic Mastocytosis
02/2004
1Atherosclerosis
11/2003
1Atherosclerotic Plaque (Atheroma)
11/2003
1Disseminated Intravascular Coagulation
08/2003
1Abscess
08/2003
1Second Primary Neoplasms (Neoplasms, Second)
03/2003
1Blast Crisis (Blast Phase)
05/2002
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2002
1Cytopenia
05/2002

Drug/Important Bio-Agent (IBA)

14CladribineFDA LinkGeneric
05/2022 - 03/2003
4Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014 - 09/2003
3LigandsIBA
02/2012 - 12/2004
2Purine NucleosidesIBA
11/2019 - 10/2010
2VemurafenibIBA
01/2019 - 10/2015
2Pharmaceutical PreparationsIBA
10/2015 - 05/2002
2Vincristine (Oncovin)FDA LinkGeneric
12/2014 - 09/2003
2Rituximab (Mabthera)FDA Link
12/2014 - 08/2003
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2014 - 09/2003
2Prednisone (Sone)FDA LinkGeneric
12/2014 - 09/2003
2pegfilgrastim (Neulasta)FDA Link
12/2014 - 05/2010
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2014 - 09/2003
2Polysaccharides (Glycans)IBA
02/2012 - 06/2010
2Proteins (Proteins, Gene)FDA Link
01/2006 - 08/2003
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2021
1ibrutinibIBA
04/2016
1purineIBA
10/2015
1Phosphotransferases (Kinase)IBA
10/2014
1fludarabineIBA
10/2010
1Liposomes (Liposome)IBA
06/2010
1CarbohydratesIBA
06/2010
1Sialic Acid Binding Immunoglobulin-like LectinsIBA
06/2010
1KD 5170IBA
05/2008
1VorinostatFDA Link
05/2008
1Histone Deacetylases (Histone Deacetylase)IBA
05/2008
1Docetaxel (Taxotere)FDA Link
05/2008
1Histone Deacetylase InhibitorsIBA
05/2008
1CytokinesIBA
01/2006
1arginyl-glycyl-aspartic acidIBA
12/2004
1AntibodiesIBA
12/2004
1Immunoglobulins (Immunoglobulin)IBA
12/2004
1Monoclonal AntibodiesIBA
12/2003
1OzoneIBA
11/2003
1SteroidsIBA
11/2003
1CholesterolIBA
11/2003
1Apolipoprotein B-100 (Apo B 100)IBA
11/2003
1LipidsIBA
11/2003
1Filgrastim (Neupogen)FDA Link
09/2003
1VitronectinIBA
08/2003
1IntegrinsIBA
08/2003
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
08/2003
1Matrix Metalloproteinases (MMPs)IBA
08/2003
1Integrin alphaVbeta3IBA
08/2003
1Metalloproteases (Metalloproteinases)IBA
08/2003
1Fibrinogen (Factor I)FDA Link
08/2003
1adhesion receptorIBA
08/2003
1Imatinib Mesylate (Gleevec)FDA Link
05/2002

Therapy/Procedure

10Therapeutics
02/2022 - 05/2002
5Drug Therapy (Chemotherapy)
11/2016 - 10/2006
3Aftercare (After-Treatment)
01/2019 - 03/2003
1Drug Tapering
10/2015